Skip to main content

25 July 2019

As part of the Board’s normal succession planning the Board is pleased to announce the appointment of Pam Cheng as an independent non-executive Director.  The appointment will take effect from 1 March 2020.  On joining the Board Pam will become a member of the Nomination & Governance, Audit & Risk and Remuneration Committees. Biographic details are set out below.

Smiths Chairman Sir George Buckley said:

“I am delighted that Pam has agreed to join the Smiths Board.

Pam’s experience in the areas of manufacturing, supply chain and technology gained with large global businesses in strategically important regions for Smiths will further strengthen the Board’s discussions on embedding world class operations.”

Biographic information:

Pam Cheng, Executive Vice-President, Operations and Information Technology, joined AstraZeneca in June 2015 after having spent 18 years in Global Manufacturing, Supply Chain and Commercial roles at Merck/MSD.  Pam Cheng was President of MSD China, responsible for MSD’s entire business in China prior to joining AstraZeneca.  She was the Head of Global Supply Chain Management & Logistics for Merck from 2006 to 2011 and led the transformation of Merck supply chains across the global supply network. Prior to joining Merck, she held various engineering and project management positions at Universal Oil Products, Union Carbide Corporation and GAF Chemicals. Pam is also an independent non-executive Director of the US listed company Codexis Inc.  Pam holds Bachelor’s and Master’s degrees in chemical engineering from Stevens Institute of Technology in New Jersey and an MBA in marketing from Pace University in New York.

There is no further information required to be disclosed pursuant to LR 9.6.13.




Investor enquiries

Jemma Spalton, Smiths Group
+44 (0)20 7004 1637
+44 (0)78 6739 0350

Marion Le Bot, Smiths Group
+44 (0)20 7004 1672
+44 (0)75 8315 4386

Media enquiries

Deborah Scott, FTI Consulting
+44 (0)20 3727 1459
+44 (0)797 953 7449

Alex Le May, FTI Consulting
+44 (0)20 3727 1308
+44 (0)7702 443 312

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11


About Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). Its businesses share common characteristics (well-positioned in growing markets, technology-led, asset-light, digitising, with a high proportion of aftermarket revenues) and a common operating model (The Smiths Excellence System). For more information visit

Related articles

Mobile Scanner

Advanced X-ray screening equipment used to help secure NFL Super Bowl

Find out more Call to action arrow icon
Japan Airport

Smiths Detection technology to be used at Fukuoka International Airport 

Find out more Call to action arrow icon
Green Scape

Smiths Group receives SBTi validation for net zero targets

Find out more Call to action arrow icon